TomoTherapy Incorporated
(NASDAQ:TOMO) announced today that it has begun shipping a faster
version of its proven platform for image-guided, intensity-modulated
radiation therapy (IG-IMRT). Version 3.1 of the TomoTherapy®
Hi-Art®
treatment system includes new software and hardware features that
enhance clinical productivity and system usability, and are expected to
increase patient throughput.
During December, TomoTherapy conducted a time-on-task study to assess
the Hi-Art system version 3.1 enhancements in a clinical setting.
Results show savings of up to 5 minutes per patient have been achieved
over previous versions, based on a standard 20-minute treatment slot.
"We couldn’t be
happier with the changes TomoTherapy has made,”
said Dr. Lane Rosen, director of radiation oncology at the Shreveport,
La.-based Willis-Knighton Cancer
Center, a version 3.1 pilot site. "We
were previously treating 20 to 25 patients a day with the Hi-Art
system. Now, we can treat as many as 30 patients a day, with no
compromise in the quality we’ve come to
expect from this revolutionary technology.”
Said Fred Robertson, CEO of TomoTherapy: "We
are very pleased to make Hi-Art 3.1 available to the radiation
oncology community. This release demonstates that a cancer center doesn’t
have to choose between reducing treatment times and delivering superior
radiation therapy. The TomoTherapy Hi-Art treatment system
empowers clinics to do both, with confidence.”
Software highlights of Hi-Art version 3.1 include a variety of
delivery system design improvements that eliminate delays in the
treatment process. Hardware updates include the addition of a second
planning workstation to facilitate parallel clinical workflow, and the
introduction of the new High Performance Couch, which provides
efficiencies in the quality assurance, imaging and treatment processes.
All Hi-Art system orders shipped beginning Jan. 2, 2008 include
the software and hardware features of version 3.1. Existing TomoTherapy
customers will receive the software upgrade free of charge.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the
TomoTherapy® Hi-Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi-Art treatment system
combines integrated CT imaging with conformal radiation therapy to
deliver sophisticated radiation treatments with speed and precision
while reducing radiation exposure to surrounding healthy tissue. The
company is traded on the
Nasdaq Global Select Market under the symbol
TOMO. To learn more about TomoTherapy, please visit www.TomoTherapy.com.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, the TomoTherapy logo and Hi-Art are among
trademarks, service marks or registered trademarks of TomoTherapy
Incorporated.
